NCT07623798
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- ZhongShan Hospital FuDan University Shanghai, Shanghai Municipality, China
Clinical trial condition
Recurrence
Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.
2,359 public trials
538 recruiting studies
Recurrence trial results
NCT07341191
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- BCCA - Vancouver Vancouver, British Columbia, Canada
- University Health Network Toronto, Ontario, Canada
- Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
NCT05798819
- Conditions
- Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
- Locations
-
- Fudan University Shanghai Cancer Hospital Shanghai, Shanghai Municipality, China
NCT07343934
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States
Recruiting
ELISA in Relapsed/Refractory MM
NCT06832865
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT06096038
- Conditions
- Disease Attributes, Head and Neck Cancer, Head and Neck Neoplasms, +8 more
- Locations
-
- Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill Chapel Hill, North Carolina, United States
NCT06173518
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +24 more
- Locations
-
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
- Methodist Children's Hospital San Antonio, Texas, United States
- Primary Children's Hospital Salt Lake City, Utah, United States
- Hospital Vall d'Hebron Barcelona, Spain
Recruiting
A Phase 3 Study of Manganese-primed Immunochemotherapy in Patients With Advanced Ovarian Cancer
NCT07822646
- Conditions
- Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +17 more
- Locations
-
- Department of Obstetrics and Gynecology, Seventh Medical Center, Chinese PLA General Hospital Beijing, Beijing Municipality, China
- Department of Bio-therapeutic, First Medical Center, Chinese PLA General Hospital Beijing, Beijing Municipality, China
- Department of Obstetrics and Gynecology, First Medical Center, Chinese PLA General Hospital Beijing, Beijing Municipality, China
- Peking University International Hospital Beijing, Beijing Municipality, China
NCT04094311
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +25 more
- Locations
-
- Novartis Investigative Site Hamilton, Ontario, Canada
- Novartis Investigative Site Ottawa, Ontario, Canada
- Novartis Investigative Site Toronto, Ontario, Canada
- Novartis Investigative Site Toronto, Ontario, Canada
NCT05554939
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- School of phamaceutical, Tsinghua University Beijing, Beijing Municipality, China
- Biotherapeutic Department, Chinese PLA General Hospital Beijing, China